期刊文献+

糖皮质激素联合地屈孕酮对不明原因复发性流产患者IL-11R、GM-CSF的影响 被引量:6

Effects of glucocorticoid combined with dydrogesterone for treating patients with unexplained recurrent abortion on the levels of their interleukin-11R and granulocyte-macrophage colony stimulating factor
下载PDF
导出
摘要 目的:探讨糖皮质激素联合地屈孕酮对不明原因复发性流产患者白细胞介素-11R(IL-11R)、粒-巨噬细胞集落刺激因子(GM-CSF)的影响。方法:选择2017年3月-2019年3月在本院接受治疗的107例不明原因复发性流产患者,随机数表法分为联合组(54例)和单药组(53例)。单药组给予地屈孕酮治疗,联合组给予糖皮质激素联合地屈孕酮治疗。比较两组临床疗效、血清IL-11R、GM-CSF、凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)、孕酮(P)、雌二醇(E2)、β绒毛膜促性腺激素(β-HCG)变化情况及不良反应。结果:治疗后,联合组总有效率(92.6%)高于单药组(73.6%),两组血清GM-CSF均下降且联合组低于单药组,两组IL-11R均上升且联合组高于单药组(P<0.05);两组血清FIB均下降且联合组低于单药组,两组APTT、TT均上升且联合组高于单药组,两组血清P、E2、β-HCG均上升且联合组高于单药组(均P<0.05)。联合组成功分娩率(85.2%)高于单药组(66.0%),异位妊娠(1.9%)、再次流产率(0)低于单药组(13.2%、11.3%)(P<0.05);两组不良反应发生率(5.6%、9.4%)无差异(P>0.05)。结论:不明原因复发性流产患者应用糖皮质激素联合地屈孕酮治疗效果显著,可有效改善患者血清IL-11R、GM-CSF水平,安全性较好。 Objective:To study the effects of glucocorticoid combined with dydrogesterone for treating patients with unexplained recurrent abortion on the levels of their interleukin-11R(IL-11R)and granulocyte-macrophage colony stimulating factor(GM-CSF).Methods:107 patients with unexplained recurrent abortion were selected and divided into study group and control group by random number table method from March 2017 to March 2019.53 women in the control group were given dydrogesterone only,and 54 women in the study group were given glucocorticoid combined with dydrogesterone.The clinical efficacy,the changes of the levels of serum IL-11R and GM-CSF,the values of activated partial thromboplastin time(APTT)and thrombin time(TT),and the levels of fibrinogen(FIB),progesterone(P),estradiol(E2),andβ-human chorionic gonadotropin(β-HCG),and the rate of adverse reactions of the patients were compared between the two groups.Results:After treatment,the total effective rate of the patients in the study group was 92.6%,which was significant higher than that(73.6%)of the patients in the control group(P<0.05).The level of serum GM-CSF of the patients in both groups had decreased significantly,and which of the patients in the study group was significant lower than that of the patients in the control group.The IL-11R level of the patients in both groups had increased significantly,and which of the patients in the study group was significant higher than that of the patients in the control group(P<0.05).The level of serum FIB of the patients in both groups had decreased significantly,and which of the patients in the study group was significant lower than that of the patients in the control group.The APTT and TTIL-11R values,and the levels of P,E2,andβ-HCG of the patients in both groups had increased significantly,and which of the patients in the study group were significant higher than those of the patients in the control group(all P<0.05).The rate of successful delivery(85.2%)of the patients in the study group was significant higher than that(66.0%)of the patients in the control group.The rate of ectopic pregnancy(1.9%)and the rate of abortion again(0)of the patients in the study group were significant lower than those(13.2%and 11.3%)of the patients in the control group(P<0.05).There was no significant difference in the incidence of adverse reactions(5.6%vs.9.4%)of the patients between the two groups(P>0.05).Conclusion:Glucocorticoid combined with dydrogesterone for treating patients with unexplained recurrent abortion has significant effect,which can effectively improve the serum levels of IL-11R and GM-CSF with better safety.
作者 胡玉海 王晶 HU Yuhai;WANG Jing(Hankou Hospital,Wuhan, Hubei Province, 430012)
出处 《中国计划生育学杂志》 2021年第8期1664-1668,共5页 Chinese Journal of Family Planning
关键词 不明原因复发性流产 地屈孕酮 糖皮质激素 白细胞介素-11R 粒-巨噬细胞集落刺激因子 Unexplained recurrent abortion Dydrogesterone Glucocorticoids Interleukin-11R Granulosa-macrophage colony stimulating factor
  • 相关文献

参考文献16

二级参考文献135

  • 1鲁蓉,伍招娣.IL-8,MCP-1,RANTES与妊娠的研究进展[J].国际病理科学与临床杂志,2005,25(4):360-363. 被引量:6
  • 2张建平,林其德,李大金,罗颂平,张清学,冯淑英,刘玉昆.复发性流产的诊断与治疗[J].现代妇产科进展,2006,15(7):481-492. 被引量:210
  • 3林其德,汪希鹏.原因不明复发性流产的病因病理生理机制与治疗研究进展[J].中国实用妇科与产科杂志,2007,23(1):5-8. 被引量:65
  • 4曹泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2004:2163-2169.
  • 5谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 6Practice Committee of the American Society for Reproductive Medicine.Evaluation and treatment of recurrent pregnancy loss:a committee opinion[J].Fertil Steril,2012,98(5):1103-1111.DOI:10.1016/j.fertnstert.2012.06.048.
  • 7Royal College of Obstetricians and Gynaecologists.The investigation and treatment of couples with recurrent first- trimester and second-trimester miscarriage (Green-top Guide- line No.17).April 2011[EB/OL].[2015-06-08].https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_17.pdf.
  • 8Salim R,Regan L,Woelfer B,et al.A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage[J].Hum Reprod,2003,18(1):162-166.D01:10.1093/humrep/ deg030.
  • 9Berghella V,Odibo AO,To MS,et al.Cerclage for short cervix on ultrasonography:meta-analysis of trials using individual patient-level data[J].Obstet Gynecol,2005,106(1):181-189.DOI:10.1097/01.AOG.0000168435.17200.53.
  • 10Drakeley AJ,Roberts D,Alfirevic Z.Cervical cerclage for prevention of preterm delivery:meta-analysis of randomized trials[J].Obstet Gynecol,2003,102(3):621-627.DOI:10.1016/ s0029-7844(03)00673-2.

共引文献764

同被引文献76

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部